ANNA WILDER: Open Payments
NPI 1013514892 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,718 in 91 payments from 28 companies in 2025. Trend: 2023 $1,406 · 2024 $2,462 · 2025 $1,718
Food & beverage: $1,718
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $287 |
| AstraZeneca Pharmaceuticals LP | 6 | $164 |
| PFIZER INC. | 9 | $156 |
| Lilly USA, LLC | 8 | $135 |
| Phathom Pharmaceuticals, Inc. | 2 | $130 |
| Xeris Pharmaceuticals, Inc. | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $82 |
| Abbott Laboratories | 3 | $60 |
| Amgen Inc. | 3 | $58 |
Products named: Ozempic, VOQUEZNA, FARXIGA, MOUNJARO, NURTEC ODT, XIFAXAN, JARDIANCE, FREESTYLE LIBRE 3.
Industry payments across VA — which companies pay providers there.
